Danielle Antin-Ozer

Dr. Danielle Antin-Ozerkis is a distinguished Associate Professor of Medicine in the Pulmonary division at Yale School of Medicine. She serves as the Medical Director of the Yale Interstitial Lung Disease Center of Excellence, where she plays a pivotal role in advancing the understanding and treatment of interstitial lung diseases (ILD). Her expertise encompasses a range of ILDs, with a particular focus on idiopathic pulmonary fibrosis (IPF) and connective tissue disease-associated interstitial lung disease (CTD-ILD). Dr. Antin-Ozerkis earned her medical degree from the University of Pennsylvania Medical School, where she also completed her residency and fellowship in Pulmonary and Critical Care Medicine. Her comprehensive training has equipped her with the skills and knowledge necessary to tackle complex pulmonary conditions, making her a leading figure in her field. Her research is primarily centered on elucidating the mechanisms that drive the development and progression of pulmonary fibrosis. Through her work, Dr. Antin-Ozerkis aims to uncover novel therapeutic targets and improve patient outcomes. She is actively involved in clinical research and drug trials, contributing to the development of new treatments for IPF and other forms of pulmonary fibrosis. In addition to her research endeavors, Dr. Antin-Ozerkis is dedicated to patient care and education. She is committed to providing high-quality, evidence-based care to her patients, while also mentoring the next generation of medical professionals. Her passion for teaching and patient care is evident in her daily interactions with students, colleagues, and patients alike. Dr. Antin-Ozerkis's contributions to the field of pulmonary medicine have been recognized through numerous awards and publications. Her work continues to influence the way interstitial lung diseases are understood and treated, making her an invaluable asset to the medical community.